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Summary
Sequential modifications of the RNA polymerase II (Pol II) carboxyl-terminal domain (CTD) 
coordinate the stage-specific association and release of cellular machines during transcription. 
Here we examine the genome-wide distributions of the “early” (phospho-serine 5), “mid” 
(phospho-serine 7) and “late” (phospho-serine 2) CTD marks. We identify gene-class specific 
patterns and find widespread co-occurrence of the CTD marks. Contrary to its role in 3’ 
processing of non-coding RNA, the Ser7-P marks are placed early and retained until transcription 
termination at all Pol II-dependent genes. Chemical-genomic analysis reveals that the promoter-
distal Ser7-P marks are not remnants of early phosphorylation, but are placed anew by the CTD 
kinase Bur1. Consistent with the ability of Bur1 to facilitate transcription elongation and suppress 
cryptic transcription, high levels of Ser7-P are observed at highly transcribed genes. We propose 
that Ser7-P could facilitate elongation and suppress cryptic transcription.
Introduction
The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) 
orchestrates dynamic interactions with proteins that are required for various stages of 
transcription 1. The structural plasticity of the CTD and its proximity to the RNA exit tunnel 
of the polymerase enables it to interact with multiple protein complexes, including those that 
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process the nascent transcript (Supplementary Fig. 1). The CTD is composed of 26 repeating 
heptapeptides (Y1S2P3T4S5P6S7) in budding yeast. Five of the seven residues (Y1, S2, T4, 
S5, and S7) can be phosphorylated or glycosylated and the proline residues (P3 and P6) can 
exist in two stereoisomeric states (cis/trans). The stage-specific association and exchange of 
protein partners is mediated by sequential post-translational modifications of different 
residues of the heptapeptide repeats 1-4. During transcription initiation, Ser5 residues of the 
CTD are phosphorylated by the Cdk7/Kin28 subunit of TFIIH and by the Cdk8/Srb10 
subunit of the Mediator complex 5-10. This “early” modification releases Pol II from the 
promoter bound preinitiation complex 8,11 and facilitates the association of the capping 
enzyme complex and the Set1 histone methyltransferase 12-16. Shortly after promoter 
release, Rtr1, an atypical phosphatase, erases the phospho-Ser5 (Ser5-P) marks on the 
elongating Pol II 17. Next, the Cdk9 kinase of the P-TEFb complex phosphorylates the Ser2 
residues of the CTD 7,18. This “late” post-translational mark facilitates transcription 
elongation, as well as the association of splicing factors and the Set2 histone 
methyltransferase that places repressive marks to prevent cryptic transcription within coding 
regions 1,4,19,20. In Saccharomyces cerevisiae, the role of Cdk9 is split between two 
homologous kinases Ctk1 and Bur1 21. Ctk1 is the primary Ser2 kinase whereas Bur1 is 
thought to stimulate elongation and suppress cryptic transcription by acting on non-CTD 
substrates 21-25. Toward the end of the coding region, the phospho-Ser2 marks (Ser2-P) are 
recognized in conjunction with the polyadenylation sequence by proteins involved in 
polyadenylation of the nascent transcript 26-28. During transcription termination, Fcp1 and 
Ssu72, two CTD phosphatases, de-phosphorylate the CTD, making it available for the next 
cycle of transcription 29-31. In mammalian cells, phospho-Ser7 (Ser7-P) marks are important 
for recruitment of the Integrator, a complex that plays an important role in 3’ processing of 
non-coding RNA 32,33. While the substitution of this evolutionarily conserved residue with 
an alanine (S7A) has modest affects on growth, the substitution with a charged glutamic acid 
(S7E) is lethal 34,35. Thus, the placement and more importantly the removal of this 
phosphate moiety plays a critical role in the transcription cycle.
The CTD code hypothesis posits that sequential CTD marks specify a stage-specific 
recognition code in a manner akin to the histone code 1-3,7,36,37. Whether or not the patterns 
that underlie the CTD code are retained across different classes of genes in the genome 
remains a fundamentally important question. The observations that Ser2-P marks are not 
required for the expression of the p53-regulated p21 gene, histone genes or snRNA genes 
raises the spectre that this mark is not universally needed for RNA synthesis 38,39. The early 
Ser5-P mark, thought to be essential for promoter release, is largely dispensable for mRNA 
synthesis 8,40-42. Despite its role in 3’ processing of non-coding genes 32,34, the Ser7-P mark 
is observed at promoters of all Pol II transcribed genes 43-45. It is unclear what role Ser7-P 
marks play at protein-coding genes. Furthermore, the crosstalk between different 
modifications is an important, but poorly understood phenomenon. Early experiments 
suggested that Ser5-P and Ser2-P modifications were placed independently 29. In fact, 
inhibition of one mark was shown to increase the abundance of the other, suggesting an 
antagonistic relationship 46. However, recently Ser5-P was shown to prime the CTD for 
subsequent phosphorylation of Ser2 by Bur1/Cdk9 22,47,48. Importantly, the interdependence 
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and co-occurrence of Ser7-P is only now beginning to be explored. Thus, many questions 
about the universality of the sequential patterning of CTD marks remain to be resolved.
Our genome-wide analysis reveals an unexpected degree of co-occurrence of all three CTD 
marks, suggesting a bivalent or even multivalent mode of recognition by docking partners. A 
particularly surprising observation is that Ser7-P is placed early in transcription and retained 
at significant levels until transcription termination. Chemical inhibition studies demonstrate 
that the promoter-distal Ser7-P marks are not remnants of early phosphorylation events, but 
are replenished by Bur1. This defines a new role for Bur1 and suggests that Ser7-P marks 
are important for efficient transcription elongation. Finally, while we highlight the 
differential patterns of CTD marks at coding and non-coding genes, our genome-wide atlas 
of CTD marks serves as a general resource to identify new regulatory mechanisms that 
underlie the CTD code.
Results
Genome-wide analyses reveal unexpected profiles
To explore the universality of the CTD code, we examined the occupancy profiles of Pol II 
and the three major CTD marks across the S. cerevisiae genome. We performed chromatin 
immunoprecipitation (ChIP) experiments and identified enriched DNA fragments via high-
resolution tiled genomic microarrays (ChIP-chip). Pol II was immunoprecipitated using a 
monoclonal antibody against Rpb3, an integral subunit of the polymerase that is not 
influenced by CTD phosphorylation. CTD phosphorylations were examined using epitope-
specific antibodies (see methods for details). The high-resolution profiles revealed novel 
patterns of Pol II association across some genes while confirming known binding patterns at 
other genes (Fig. 1, traces in blue). For example, high occupancy of Pol II across the 
ribosomal protein gene RPL16B and rapid depletion of Pol II across the NRD1 gene have 
been well documented (Fig. 1a) 49. On the other hand, the enrichment of Pol II at the 3’ end 
of the MRPL4 gene or the enrichment at the 5’ and 3’ ends of the RIM1 gene are new 
findings (Fig. 1a). Although cryptic unstable transcripts (CUTs), stable unannotated 
transcripts (SUTs) 50,51, and neighboring convergent genes may contribute to some of these 
profiles, there are some genes at which there is no neighboring or overlapping transcription 
to account for the 3’ enrichment of Pol II (Supplementary Fig. 2).
We then examined the genome-wide patterns of CTD phosphorylation. To ensure that the 
profiles of CTD modifications were not skewed by unusual Pol II profiles, we focused on 
genes bearing uniformly high levels of Pol II across the transcription unit (Fig. 1b). 
Particular examples include the protein-coding (pc) genes: PDC1, COX18 and PSA1, as 
well as the non-coding (nc), polycistronic cluster: SNR78-72. The Ser7-P profile across the 
SNR cluster is enriched at the 5’ end of the gene with dissipation of the signal towards the 3’ 
end of the transcription unit. The pc-genes show different Ser7-P profiles. Unlike previous 
reports in human cells 32,34, we fail to detect Ser7-P enrichment solely in the middle of the 
coding region across the yeast genome. On the other hand, the reciprocal enrichment of 
Ser5-P at promoters and Ser2-P at the 3’ ends is frequently observed and defines the current 
paradigm. However, the levels of Ser5-P across COX18 and Ser2-P on the SNR78-72 
cluster do not conform to the paradigm and are lower than expected. The unexpected 
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patterns of CTD marks at different genes are not due to experimental variability 
(Supplementary Fig. 3) but may arise from CUTs and SUTs.
Clustering genome-wide profiles of Pol II and the three major CTD marks
To examine commonalities between patterns of Pol II and its modifications across the 
genome, we used an average transcription unit analysis (Fig. 2a). In this analysis, the entire 
transcription unit, from the transcription start site (TSS, arrow at 5’ end) to the cleavage and 
polyadenylation site (CPS, vertical red bar at the 3’ end), was represented by 10 evenly 
scaled bins across all annotated genes in the genome (see methods for details). The Pol II 
and CTD modification profiles are sorted by unrestrained k-means clustering. The profiles 
coalesce into four general clusters (Fig. 2b): uniform enrichment across the transcription unit 
(denoted by U), 5’ enrichment (denoted by 5), 3’ enrichment (denoted by 3), or 5’ and 3’ 
enrichments (denoted by 5+3). The four panels show the clustered profiles of Pol II and its 
modifications across all genes in the genome (Fig. 2b).
The compact nature of the yeast genome complicated analysis due to signal bleed-over from 
neighboring genes and their regulatory elements. Therefore, we parsed the genes into three 
sets: the first included all 6147 annotated genes in the genome, the second focused on 615 
genes that have the highest levels (top 10%) of Pol II occupancy, and the third set is 
comprised of 60 genes that display robust Pol II occupancy but are isolated from other 
known or predicted genes by at least 400 base pairs. Importantly, genes in the third set are 
also devoid of overlapping or neighboring CUTs and SUTs. The profiles of Pol II and its 
modifications across the three sets of genes are summarized as pie charts (Fig. 2c).
The summary profiles of the 60 well-isolated pc-genes (Set III) show that Ser7-P and Ser5-P 
marks are enriched at 5’ end of genes (combining 5, 5+3, U) whereas the Ser2-P mark is 
enriched at the 3’ end of genes. A quantitative fit of the profiles show that Ser5-P and Ser7-
P maxima occur within 50 bp of the start site whereas the Ser2-P marks reach their first 
maxima by 517±226 bp (Supplementary Fig. 4a-b). Unexpectedly, at ~36% of the genes, the 
Ser5-P “early” mark is also enriched at the 3’ end (5+3 profile). The non-canonical 
enrichment of Ser5-P at the 3’ ends and the occurrence of “late” Ser2-P mark at the 5’ ends 
of genes are surprising. Moreover, only 15% of the Set III genes display the canonical Ser5-
P enrichment only at the 5’ end followed by the reciprocal Ser2-P enrichment at the 3’ end 
of transcription units. Thus, the accepted paradigm that Ser5-P is enriched only at 
promoters, Ser7-P in the middle of the coding regions and Ser2-P toward the end does not 
adequately describe the patterns of CTD marks observed across the genome and therefore 
should be revised.
To assess the functional importance of Ser7-P profiles, we examined gene ontology (GO) 
enrichment within each cluster. The clusters obtained using k-means were refined using 
silhouette analysis in which scores were assigned to the genes within each cluster. A 
silhouette score gives a measure of how well a gene profile fits in a given cluster. Iterative 
optimization allowed us to obtain the highest-confidence genes for each cluster 
(Supplementary Fig. 5). We then examined the clusters to find groups of ontologically 
related genes unique to each cluster (Fig. 2d, Supplementary Fig. 6, and Supplementary 
Table 1). The strong enrichment of ribosomal biogenesis genes with the uniform (U) Ser7-P 
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profile was especially striking (P < 10−14). To further validate this result, we performed a 
hypergeometric comparison of genes within the U cluster with known genome-wide binding 
sites of all yeast transcription factors. Consistent with the GO enrichment, transcription 
factors involved in ribosome biogenesis (FHL1, RAP1, and SFP1) were significantly 
enriched in the U cluster (Supplementary Fig. 6). To examine the generality of our initial 
observations, we compared the known rates of RNA synthesis for genes within each 
cluster 52. The U cluster was enriched for highly transcribed genes. The reciprocal analysis 
of the genes transcribed at the highest frequency revealed that 86% had the U Ser7-P profile. 
(Fig. 2e and Supplementary Fig. 6c). Further comparison with genome-wide maps of 
components of the transcriptional machinery, chromatin remodeling machines, and 
transcription factors revealed that genes within the U cluster were highly enriched for factors 
that stimulate high levels of transcription (Fig. 2f and Supplementary Fig. 7) 53. In essence, 
multiple analyses of datasets from independent sources strongly tie highly expressed genes 
to uniform patterns of Ser7-P marks across the transcribed regions. Thus, Ser7-P mark may 
contribute to efficient transcription elongation.
Distinct patterns at non-coding versus protein-coding genes
Ser7-P is only thought to be important for 3’ processing of snRNA; however, it is also 
placed robustly at pc-genes. It is unknown what role this CTD mark may play at pc-genes. 
We therefore examined if the patterns of CTD marks differ between nc- and pc-genes (Fig. 
3a). The Ser7-P and Ser5-P profiles on SNR7 and SNR14 are strikingly similar but they 
differ from the profiles at pc-genes (YDJ1 and FBA1 in Fig. 3a). At pc-genes, Ser7-P and 
Ser5-P profiles coincide at the promoter but rapidly deviate within coding regions. While 
Ser5-P levels abate, Ser7-P levels are retained at high levels until the 3’ end. Moreover, 
dramatically lower levels of Ser2-P are apparent across nc-genes when compared to pc-
genes. None of the profiles display any correlation with the well-positioned nucleosomes at 
promoters of genes (Fig. 3a).
To extend the comparison beyond a few representative genes, we calculated the average 
levels of Ser7-P and Ser2-P marks for the 82 nc-genes (snRNA and snoRNA) transcribed by 
Pol II and the 60 pc-genes of Set III (from Fig. 2b). Other than distance from neighboring 
genes, the Set III pc-genes are ontologically unrelated to each other and they provide 
unambiguous occupancy profiles. The genome-scale data clearly show that the extent of 
Ser7-P modification on both classes of genes is equivalent. However, the levels of Ser2-P 
are 400% lower on nc-genes (P = 4.4×10−21) (Fig. 3b). Even when correcting for the shorter 
size of nc-genes, we find that the levels of Ser2-P are 275% lower than the signals observed 
within the first 300bp of pc-genes (P = 1.9×10−10) (Supplementary Fig. 4c). The lower 
levels of Ser2-P marks and the abundance of Ser7-P at nc-genes likely serve as a signal for 
enzymes that process nc-transcripts.
Chemical-genomic inhibition reveals crosstalk between CTD marks
To examine the crosstalk between the CTD marks, we used a chemical-genetic approach to 
inhibit the two major kinases that phosphorylate Ser5 during transcription initiation: TFIIH-
associated Cdk7/Kin28, and to a lesser extent the Mediator-associated Cdk8/Srb10 
(Supplementary Fig. 8a) 8,40. To inhibit these two kinases selectively, their ATP-binding 
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pockets were genetically altered to accept cell-permeable inhibitor analogs (Supplementary 
Fig. 8a) 8,54. Consistent with our previous studies, targeted chemical inhibition of Kin28/
Cdk7 in combination with Srb10/Cdk8 (Kin28as+Srb10as) blocks a significant portion of 
the kinase activity and leads to a rapid decrease in cell growth (Supplementary Fig. 8a) 8,40. 
Chemical inhibition of Kin28as+Srb10as in vivo leads to a precipitous decrease in Ser5-P 
marks at the 5’ end of several genes (SED1 in Fig. 4a). Unexpectedly, under similar 
treatment Ser7-P marks are only attenuated at the promoter. The promoter-proximal loss of 
both marks is particularly evident upon normalization to Pol II (Supplementary Fig. 8b).
To further clarify the remodeling of occupancy patterns, we examined the Set II genes that 
show uniformly high levels of Pol II occupancy throughout the transcription unit (Fig. 4b). 
The profiles from the untreated and the chemically inhibited double mutant strain were 
binned as described above (see Fig. 2). The mean of 415 genes is displayed (Fig. 4b). Upon 
inhibition, the Pol II profile shows clear decrease in the middle of the coding region 
resulting in a bimodal distribution with peaks at the 5’ and 3’ ends of the transcription unit 
(profile I5’+3’). Ser5-P and Ser7-P marks are dramatically reduced at 5’ ends but they are 
unperturbed within coding regions. In agreement with recent reports 47,48, this decrease in 
Ser5-P leads to a subtle but detectable decrease in Ser2-P. However, it is important to note 
that in contrast to Ser5-P and Ser7-P, the overall profile of the Ser2-P mark does not change.
We then examined the consequences of inhibiting Kin28as+Srb10as across the genome (Fig. 
4c and Supplementary Fig. 10). The profile clusters for the inhibited strain resemble those 
seen previously (U, 5, 3, 5+3), but they were labeled with an “I” (inhibitor treated) to 
differentiate them from the clusters from the untreated wild type strain (Fig. 2c and Fig. 4c). 
Using this nomenclature, we compared the profiles from wild type strains (central pie charts: 
U, 5, 3, 5+3) with the profiles for the same genes in the chemically inhibited Kin28as
+Srb10as strain (surrounding pie charts: IU, I5, I3, I5+3; Fig. 4c and Supplementary Fig. 10). 
The inhibition data for Pol II is striking, as a significant fraction of genes from the uniform 
and 5’-enriched clusters (U, 5) are altered to the 5’+3’ enriched profile (I5+3 in dashed 
circles). In addition, the Ser7-P profiles are remodeled with a loss of 5’-enriched patterns 
and an increase of 3’ enrichment (I3) within the coding regions. Ser5-P profiles are also 
remodeled, as the 5’-enrichment is lost. The 3’-enriched fraction of Ser2-P profiles is not 
dramatically altered. Taken together, the data indicate that promoter-proximal Ser5-P and 
Ser7-P marks are strongly coupled, whereas promoter-distal Ser2-P and Ser7-P marks are 
not strictly dependent on early CTD marks. The coupling of Ser5-P and Ser7-P at promoters 
is consistent with the role of Kin28/Cdk7 in phosphorylating these residues 43-45. However, 
the occurrence of Ser7-P within coding regions is unexpected.
An internal Ser7 kinase acts within coding regions of pc-genes
To determine if Ser7-P marks detected within coding regions are not remnants of marks 
placed at the promoter we examined the distribution of this mark at the inducible GAL1 
gene. We first inhibited Kin28as+Srb10as for 60 minutes in non-inducing conditions. Under 
these conditions, we detect no Pol II at the GAL1 promoter and have previously shown that 
both Kin28as and Srb10as remain chemically inhibited 8,40. Next, we induce the GAL genes 
for 30 minutes, and use ChIP-qPCR to examine the distribution of Pol II and Ser7-P marks 
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at the 5’ and 3’ ends of the GAL1 gene (Fig. 5a). The data reveal an unambiguous 
diminution of Ser7-P marks at the 5’ end and a robust signal for this mark at the 3’ end. In 
other words, the internal Ser7-P marks are placed anew by a different kinase(s), one that is 
not sensitive to inhibitors of Kin28as and Srb10as.
To explore if internal Ser7-P marks are also placed anew in nc-genes, we compared the 
changes in the Ser7-P profiles at pc- and nc-genes that are of similar length and have similar 
polymerase occupancy. The SNR78-72 polycistronic cluster and GLN1 gene display 
comparable levels of Ser7-P and Ser5-P marks at the promoter and are equally responsive to 
the inhibitor at the 5’ end (Fig. 5b). However, in contrast to GLN1, Ser7-P marks are not 
replenished at the 3’ end of the SNR78-72 cluster. We systematically examined the levels of 
Ser7-P marks at the 3’ end of 82 nc-genes and the 60 pc-genes from Set III (Fig. 5c). The 
data unambiguously demonstrate that inhibiting promoter-proximal kinases leads to a 
dramatic loss of Ser7-P at nc-genes but not at pc-genes. Thus, chemical-genomic analysis 
reveals the existence of a Ser7 kinase that acts on elongating polymerases.
To identify the internal Ser7 kinase, we purified the four kinases that phosphorylate the CTD 
during different stages of transcription: Kin28/Cdk7, Srb10(Srb11)/Cdk8, Bur1/Cdk9, and 
Ctk1/Cdk9 (Supplementary Fig. 1). Consistent with our previous work, Kin28 
phosphorylated Ser5 and Ser7 residues on a GST fusion protein bearing four or more 
heptapeptide repeats (Fig. 6a) 43. While Bur1 does not phosphorylate substrates bearing 
three heptapeptide repeats54, it phosphorylates Ser7 on substrates bearing four or fourteen 
repeats (Fig. 6a and Supplementary Fig. 11a). Our results are consistent with recent reports 
of Bur1 preferentially phosphorylating longer CTD substrates 37. The kinase activity was 
quantified using an ELISA (Fig. 6b). Importantly, neither Srb10 nor the control Cka1 kinase 
phosphorylated Ser7 in parallel assays (Supplementary Fig. 11a).
To validate these observations, we used a strain where Bur1 was engineered to bind a bulky 
purine analog, 3-MB-PP1 22. Unlike the wild type enzyme, the enlarged ATP-binding site of 
the engineered Bur1 (Bur1as) is inhibited by 3-MB-PP1 and can utilize the bulky ATP 
analog N6-benzyl-ATP to phosphorylate Ser7 in vitro (Fig. 6c). The inhibitor has only a 
modest affect on the growth rate of Bur1as cells, suggesting a partial in vivo inhibition of 
this kinase whose function is vital for cell viability (Supplementary fig. 11b). However, this 
degree of inhibition is sufficient to reduce the ability of Bur1 to modify Spt5 or CTD in 
vivo 22,48 In agreement with its in vitro activity, chemical inhibition of the Bur1as strain led 
to a loss of Ser7-P marks in vivo at the SNR cluster and GLN1 (Supplementary Fig. 11d). 
This loss of Ser7-P within the coding region is not observed in chemically treated isogenic 
wild type strain or the Kin28as+Srb10as strain (Supplementary Fig. 11c). In contrast, the 
loss of Ctk1 nearly abolishes Ser2-P marks but has no affect on Ser7-P at the SNR cluster 
and the internal site of GLN1. The decrease in Ser7-P levels at GLN1 in ctk1Δ strain may 
result from latent Ser7-P activity of this kinase in vivo, or the inability of Pol II to release 
basal transcription factors in the absence of Ctk1 55.
To examine the genome-wide contribution of Bur1 to Ser7-P profiles, we performed ChIP-
chip analysis on the Bur1as strain in the presence or absence of the inhibitor. Unlike the 
promoter-proximal decrease in Ser7-P upon inhibition of Kin28as+Srb10as, inhibition of 
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Bur1 reduces Ser7-P within the coding region (Fig. 6d). The summarized data on Set II 
genes with uniformly Pol II profiles show that the decrease is most apparent within the 
coding region, with the greatest effect toward the 3’ end (Fig. 6e). Moreover, a direct 
comparison of changes in Ser7-P levels upon chemical inhibition of Kin28as+Srb10as or 
Bur1as further highlights the role of Kin28 at the 5’ end and Bur1 at the 3’ end of genes 
(Fig. 6f). The results are consistent with the ability of Bur1 to act on elongating polymerases 
from promoter-proximal regions until the 3’ end of genes.
Discussion
This study provides the first genome-wide atlas of CTD modifications that orchestrate stage-
specific processes in RNA biogenesis. The data reveal: 1) ubiquitous co-occurrence of CTD 
marks across the transcribed units, 2) existence of gene-class specific patterns of Pol II and 
its modifications, 3) weak coupling between promoter-proximal and promoter-distal CTD 
marks, 4) Ser7-P marks within coding regions are placed anew and are not remnants of 
marks placed by Kin28 at the promoter, and 5) a novel role of Bur1 as a Ser7 kinase that 
acts on elongating Pol II. When considered in its entirety, our data suggest that accepted 
paradigms underlying the “CTD code” should be revised to accommodate combinatorial 
patterns of CTD modifications.
The widespread co-occurrence of CTD marks does not mean that they are placed at 
equivalent levels at all genes across the genome. We observe distinct patterns of the three 
marks between nc- and pc-genes. Ser7-P closely mirrors the patterns of Ser5-P across the 
entire nc-gene, whereas at pc-genes the Ser7-P mark persists well beyond the point where 
Ser5-P levels drop significantly. Moreover, Ser2-P marks are underrepresented at nc-genes, 
even when length of the transcript is taken into consideration. The distinct patterns of CTD 
marks at these two gene classes reflect the different mechanisms of transcription termination 
and 3’ end processing that act on these two classes of RNA 49,56-59.
The co-occurrence of CTD marks is consistent with our observation that two kinases known 
to phosphorylate the CTD also place bivalent marks. We and others previously identified the 
ability of Kin28/Cdk7 to phosphorylate Ser5 and Ser7 43-45. Because, Kin28/Cdk7 
associates with Pol II at promoters, the co-occurrence of Ser5 and Ser7 marks within 50 bp 
of the transcription start site can be ascribed to the action of Kin28/Cdk7. We also show that 
Srb10, another Ser5 kinase, does not contribute to Ser7-P marks at promoters or within 
coding regions (Fig. 4). Inhibition of Kin28as+Srb10as revealed, for the first time, the 
existence of other kinases that act on Ser7 residues of the elongating polymerase. A series of 
kinase assays on CTD substrates bearing more than three heptapeptide repeats revealed that 
Bur1 phosphorylates Ser7. The requirement for longer CTD substrates was previously noted 
in studies that examined the ability of Bur1 to phosphorylate Ser2 48. The inhibition of 
Bur1as with cell permeable inhibitors further confirmed its role as a Ser7-P kinase in vivo 
(Fig. 6d-e, Supplementary Fig. 11c-d). This is a new role for Bur1, one that couples the 
placement of Ser7-P with Ser2-P on elongating polymerases.
In performing these experiments, we were surprised to find that promoter-distal Ser7-P 
marks were not eliminated by inhibition of the promoter-proximal Ser7 kinase. This 
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observation is inconsistent with the notion that promoter-distal Ser7-P marks were remnants 
of the marks placed by Kin28 at the promoter. Similarly, promoter-distal Ser2-P and Ser5-P 
marks were not eliminated upon simultaneous inhibition of promoter-proximal Ser5 kinases 
(Srb10 and Kin28). Moreover, it was recently suggested that promoter-proximal Ser5-P 
marks were critical for sequential placement of Ser2-P marks on the elongating Pol II. Thus, 
contrary to the expectation that early marks prime the CTD for subsequent modifications, 
our data indicate that promoter-distal placement of CTD modifications is not acutely 
dependent on early marks.
Previous mutational analyses highlight the importance of dynamic placement of Ser7-P 
marks. The substitution of Ser7 with a glutamic acid (S7E) is lethal whereas the inability to 
phosphorylate this position (S7A in T4A containing CTDs) only results in a decreased 
growth rate at suboptimal temperatures 34,35. The removal and replenishment of Ser7-P 
marks within coding regions may serve as a critical signal for the exchange of factors during 
the transition from promoter-release to productive elongation. A role for Ser7-P in efficient 
elongation is consistent with the observation that highly transcribed genes show high levels 
of this CTD mark. Moreover, the ability of Bur1 to place this mark is consistent with its 
ability to associate with transcribing Pol II and stimulate transcriptional elongation 24,25. In 
addition to improving elongation via phosphorylation of Spt5 22,23, Bur1-mediated 
placement of Ser7-P marks could help recruit cellular machinery that facilitates elongation 
and suppresses cryptic transcripts. This could well explain why Ser7-P marks are observed 
across all protein-coding genes even though their function is only defined at non-coding 
genes.
Methods
Genome-wide location and transcriptional analyses
Chromatin immunoprecipitation (ChIP), with antibodies against Pol II (αRPB3) and the 
Ser7-P (4E12), Ser5-P (H14), and Ser2-P forms of Pol II, was performed as described 
previously with several modifications1 (see Supp. Methods). The ChIP samples were 
amplified using ligation-mediated PCR and hybridized to high density tiling microarrays 
from NimbleGen (Roche NimbleGen, Inc.; Madison, WI). Total RNA samples were 
isolated, prior to formaldehyde crosslinking, during the ChIP experiments, and were 
processed by Roche NimbleGen hybridization to high density tiling microarrays having the 
same design as those used for the ChIP-chip experiments.
Data Analysis
ChIP-chip Immunoprecipitated (IP) data was mean-scaled against its respective “Input” 
sample data and then the ratio of scaled IP to the Input was Log2 transformed. For total 
RNA data, the probe intensities were divided by the peak intensity from the raw data 
histogram and then Log2 transformed. Both data types were subjected to computational 
repeat sequence masking based on probe sequence repetitiveness relative to the sequence 
composition of the probes on the microarray (see Supp. Methods). A moving average was 
used to smooth the microarray data, and baseline corrections were applied through 
comparison between polymerase and transcript data (see Supp. Methods).
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Average transcription unit analysis was applied to the data to obtain occupancy profiles 
normalized for gene length for every gene in gene sets I, II, and III. This allowed for 
alignment of the occupancy patterns for all the genes in the genome (see Supp. Methods). K-
means clustering was performed to partition the genes into categories based on their 
occupancy profiles. These clusters were then manually collapsed into four representative 
groups. Clusters were refined through iterative silhouette score calculations, cluster 
reassignments, and gene silhouette score filtering2 (see Supp. Methods). Transcription factor 
enrichments were determined via hypergeometric probabilities calculated from published 
binding data3.
Kinase Assays
The kinase assay was done as described previously4. Briefly, 200ng of GST-CTD4 or 
GSTCTD14 (four or fourteen repeats of YSPTSPS fused to GST) or its alanine substitutions 
(2A, 5A and 7A) were phosphorylated by four different kinases or whole cell extract at 25°C 
for one hour in a buffer containing 20mM HEPES [pH 7.5], 2.5mM EGTA, 15mM 
magnesium acetate, 0.8mM ATP, 10% glycerol, protease inhibitors, and phosphatase 
inhibitors [1mM NaN3, 1mM NaF, 0.4mM Na3VO3]. Four micro-liters from the reaction 
mix were directly spotted onto nitrocellulose membrane (GE Healthcare) and was processed 
further as a standard dot blotting protocol. For the assay, a 1:50(αSer2-P), 1:500(αSer5-P), 
or 1:200(αSer7-P) dilution of primary rat IgG and 1:10000 dilution of secondary HRP anti-
rat IgG (Southern Biotech) antibodies were used.
For the Bur1as inhibition study, 200ng of GST-CTD14 was used. TAP-tagged WT Bur1 and 
FLAGx3-tagged Bur1as were incubated with 5uM 3MB-PP1 for 5 minutes in kinase assay 
buffer sans ATP at room temperature. Following the inhibition, 0.8mM ATP or 0.6mM N6-
Benzyl-ATP was added and the reaction was allowed to run for 30 minutes at room 
temperature. Five micro-liters from the reaction mix were directly spotted onto 
nitrocellulose membrane and processed as a standard dot blotting protocol. For the assay, a 
1:30(αSer2-P), 1:1000(αSer5-P), or 1:100(αSer7-P) dilution of primary rat IgG and 1:12500 
dilution of secondary HRP anti-rat IgG (Southern Biotech) antibodies were used.
For ELISA, the recombinant kinase (100ng) was incubated with excess CTD-peptide 
(YSPTSPSYSPTSPSYSPTSPSYSPTSPSC; Peptide Specialty Laboratories GmbH, 
Heidelberg) linked to 96-well plates in a 25μl kinase buffer containing 20mM Tris-Cl [pH 
7.4], 20mM NaCl, 10mM MgCl2, 1μM DTT and 2μM ATP at 28°C for 60 minutes. 
Phosphorylation of CTD was quantitated via ELISA experiments after incubation with 
αSer2-P, αSer5-P and αSer7-P specific antibodies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Pol II and CTD Phosphorylation Profiles
(a) ChIP-chip profiles for representative genes chosen to display the diversity of Pol II 
profiles across the genome. Pol II is shown in blue and total RNA is shown in black. 
Translation boundaries are indicated by the black boxes, and transcription boundaries shown 
as an arrow (Transcription Start Site, TSS) and a red bar (Cleavage and Polyadenylation 
Site, CPS). Introns are marked with a ^ symbol. Scale on x-axis corresponds to distance in 
base pairs from the TSS. Scale on y-axis represents fold enrichment of IP over input on a 
Log2 scale for ChIP-chip data and fold expression over background for total RNA data. The 
cartoon beneath the plots illustrates the potential Pol II distributions that would yield the 
observed ChIP-chip occupancy profiles.
(b) ChIP-chip profiles of genes for which Pol II occupancy profile (blue) is constant across 
the ORF. Phosphorylation profiles are shown in purple (Ser7-P), red (Ser5-P), and green 
(Ser2-P) and total RNA is shown in black.
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Figure 2. Genome-wide Pol II and CTD Phosphorylation Profiles
(a) The diagram summarizes the scale used in the average transcription unit analysis. Bins 
within transcribed region are equivalent to 10% of the transcribed region length and bins 
flanking this region (−1, +1) are a constant 157bp.
(b) Representative clusters from the K-means clustering analysis for Pol II, Ser7-P, Ser5-P, 
and Ser2-P occupancy profiles across the genome using average transcription unit analysis 
(see Methods). U: uniform enrichment across the transcription unit; 5: 5’ enrichment; 3: 3’ 
enrichment ; 5+3: or 5’ and 3’ enrichments. The dominant profile(s) for each is highlighted.
(c) Pie chart diagrams displaying the distribution of genes within each gene set for Pol II, 
Ser7-P, Ser5-P, and Ser2-P having each of the profiles shown in (b). Set I –Annotated 
protein-coding genes (6147 genes); Set II – pc-genes with an average Pol II enrichment in 
the top 10% (615 genes); Set III –pc-genes isolated by 400bp and having an average Pol II 
enrichment greater than or equal to 1 (60 genes).
(d) Histogram of significantly enriched gene ontology (GO) categories within individual 
Ser7-P clusters (U, 5, 3, and 5+3). Details for each GO category are provided in 
Supplementary Table 1.
(e) Box plots of transcription frequency for genes within each Ser7-P cluster 52. The uniform 
(U) Ser7-P cluster is strongly enriched for genes with higher rates of transcription frequency 
compared to the genome average (P-value = 3.35 × 10−30).
(f) Bar graph of transcription machinery at the upstream activating sequence (UAS) within 
individual Ser7-P clusters. The individual proteins are listed in Supplementary Fig. 6. 
Proteins that are enriched within the cluster are represented by positive values, while 
proteins that are depleted are represented by negative values 53. Dashed lines segregate the 
components of each complex.
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Figure 3. CTD Phosphorylation Profile for Protein-coding and Non-coding Genes
(a) Phosphorylation profiles across several representative nc-genes (left column) and pc-
genes (right column). Color-coded arrows indicate the respective phosphorylation peak. The 
nc-genes display overlapping Ser5-P (red) and Ser7-P (purple) profiles, while varying levels 
of 3’ Ser7-P enrichment is observed in pc-genes. Ser2-P (green) appears to be less abundant 
in nc-genes. The nucleosome positions near the TSS 60 are displayed as orange circles 
(drawn to scale).
(b) Histograms displaying the relative enrichment (with respect to Pol II levels) across nc- 
and pc-genes for Ser7-P and Ser2-P. The Ser2-P levels are significantly lower in nc-genes 
than pc-genes (P-value = 4.4×10−21). No significant difference in Ser7-P was detected 
between nc-genes and pc-genes (P-value = 0.658).
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Figure 4. Small Molecule Inhibition of CTD Phosphorylation
(a) Inhibition effects on total RNA (black), Pol II (blue), Ser7-P (purple), Ser5-P (red), and 
Ser2-P (green) occupancy profiles for SED1. Uninhibited profiles are shown as a solid line 
and inhibited profiles shown with a dashed line.
(b) Summary of average Kin28as+Srb10as responses to inhibition for Pol II (blue), Ser7-P 
(purple), Ser5-P (red), and Ser2-P (green). Data displayed for 415 genes with “uniform” Pol 
II profiles from Set II in the Wild Type strain (see Supplementary Fig. 11, central Pol II 
Pie). The solid and dashed lines indicate the uninhibited and inhibited Kin28as+Srb10as 
average profiles, respectively. Scale on the x-axis is shown as distance from the TSS using 
average transcription unit analysis (described in Fig. 2a). Scale on y-axis represents fold 
enrichment of IP over input on a Log2 scale.
(c) Comprehensive diagrams displaying the comparison between the uninhibited wild type 
strain (large central pies) and the inhibited double mutant strain (smaller pies) for all the 
genes in Set III (described in Fig. 2c). Summaries shown for Pol II (blue), Ser7-P (purple), 
Ser5-P (red), and Ser2-P (green). The smaller pie charts correspond to a slice of the wild 
type chart and show the partitioning of the genes from the double mutant data within that 
slice after the inhibitor was added. The profiles U, 5, 3, and 5+3 are as described in Figure 2 
and “I” is used to indicate the profiles seen after inhibition (IU, I5, I3, and I5+3).
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Figure 5. Promoter-Distal Ser7-P Marks are Not Remnants of Promoter-Proximal Kin28 
Phosphorylation
(a) Ser7-P marks within the coding region are not remnants of phosphorylation at the 
promoter. The Kin28as+Srb10as strain was treated for 60 min with DMSO or the inhibitors 
1-NA-PP1/1-NM-PP1 under non-inducing conditions. The GAL genes were induced for 30 
minutes, and ChIP-qPCR was performed against the 5' and 3' ends of the GAL1 genes (black 
bars indicate primer location). Upon inhibition, Ser7-P was significantly reduced at the 5' 
end but not the 3' end of GAL1.
(b) Representative ChIP-chip profiles for Ser5-P (red) and Ser7-P (purple) at a nc-gene 
polycistronic cluster (SNR78-72) and a pc-gene (GLN1) demonstrating the effects of Kin28 
and Srb10 inhibition. The inhibition of Ser5-P is observed predominantly at the 5’ ends of 
both nc- and pc-genes. At nc-genes, the total level of Ser7-P decreases uniformly across the 
transcript, while at pc-genes the primary effect of the inhibition is seen at the 5’ end of the 
transcript. This suggests the presence of a secondary Ser7 kinase acting near the 3’ end of 
pc-genes (indicated by a *).
(c) Histogram demonstrating the effects of inhibition on the relative Ser7-P enrichment 
(with respect to Pol II levels) at the 3’ end of the ORF at of nc-Genes (left panel) and pc-
Genes (right panel). (nc-genes: P = 1.2×10−6; pc-genes: P = 0.716)
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Figure 6. Bur1 Kinase Directly Phosphorylates Ser7
(a) Kinase assay using a GST-CTD4 and GST-CTD14 substrates and purified Cka1, Kin28, 
and Bur1 kinases. The blots were probed with antibodies against Ser5-P (top) and Ser7-P 
(bottom).
(b) ELISA of GST-CTD4 phosphorylated by purified yeast kinases and probed with 
antibodies against Ser7-P (purple), Ser5-P (red), and Ser2-P (green).
(c) Dot blot of GST-CTD14 phosphorylated by Bur1 and the analog-sensitive mutant Bur1as 
(Bur1-L149G) probed with anti-Ser7-P antibodies.
(d) Ser7-P enrichment profile (normalized to Pol II) across the YRA1 gene showing the 
effects of inhibition of either Kin28as+Srb10as or Bur1as.
(e) Average Pol II (blue) and Ser7-P (purple) from uninhibited (solid line) and inhibited 
(dashed lines) Bur1as cells at 415 genes with uniform and robust Pol II occupancy from Set 
II (top panels). Pol II normalized fold change in Ser7-P across the same subset of genes 
(bottom panel) is shown to highlight the role of Bur1 in Ser7 phosphorylation across the 
transcribed unit.
(f) Distribution of average Pol II normalized fold changes in Ser7-P within a 10% window 
centered around the TSS and the 3’ ORF boundary of Set III genes. Distributions from 
Kin28as+Srb10as and Bur1as cells were compared using a two-sided student's T-test.
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